Ajinomoto Co., Inc.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Analyst Recommendations 14 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/05/06 | ¥41.47 | ¥46.54 | +12.2% |
| 2026/02/05 | ¥37.66 | ¥39.64 | +5.3% |
| 2025/11/05 | ¥32.01 | ¥19.56 | -38.9% |
| 2025/08/04 | ¥30.86 | ¥32.62 | +5.7% |
Shareholder Composition
Updated 2026/08/01Top Mutual Funds / ETFs
Updated 2026/08/01Major Holders
Updated 2026/08/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
13.7M | -1.68% | |
|
NEW PERSPECTIVE FUND
|
12.5M | +2.19% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
9.1M | +0.65% | |
|
Fidelity Investment Trust-Fidelity Series Overseas Fund
|
8.7M | -12.89% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
6.3M | 0.00% | |
|
Fidelity Rutland Square TRT II-Strategic Advisers Fidelity Intl Fd.
|
6.1M | -11.17% |
| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Mcmillan Office, Inc.
|
500 | +1.00% | |
|
Pacer Advisors, Inc.
|
7.5K | +2.94% |
Dividend History
Updated 2026/08/16| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥24 | -45.5% |
| 2025 | ¥44 | +14.3% |
| 2024 | ¥39 | +4.1% |
| 2023 | ¥37 | +25.4% |
| 2022 | ¥30 | - |
Financial Performance
2026/08/16 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥1,149,370M | ¥1,359,115M | ¥1,439,231M | ¥1,530,556M |
| Gross Profit | ¥425,897M | ¥470,387M | ¥511,448M | ¥550,764M |
| Operating Income | ¥123,587M | ¥144,602M | ¥141,953M | ¥107,656M |
| Pretax Income | ¥131,440M | ¥155,027M | ¥154,457M | ¥122,761M |
| Net Income | ¥75,725M | ¥94,065M | ¥87,121M | ¥70,272M |
| EPS | ¥69.71 | ¥87.98 | ¥83.70 | ¥34.88 |
| Operating Margin | 10.75% | 10.64% | 9.86% | 7.03% |
| Balance Sheet | ||||
| Total Assets | ¥1,457,060M | ¥1,511,734M | ¥1,768,371M | ¥1,721,131M |
| Total Equity | ¥686,909M | ¥768,676M | ¥815,074M | ¥746,804M |
| Total Liabilities | ¥770,151M | ¥743,058M | ¥953,297M | ¥974,327M |
| Cash | ¥151,454M | ¥132,777M | ¥171,537M | ¥164,776M |
| Interest-bearing Debt | ¥313,908M | ¥288,564M | ¥442,494M | ¥455,353M |
| Equity Ratio | 47.14% | 50.85% | 46.09% | 43.39% |
| D/E Ratio | 0.46 | 0.38 | 0.54 | 0.61 |
| Cash Flow | ||||
| Operating CF | ¥145,576M | ¥117,640M | ¥168,074M | ¥209,898M |
| Investing CF | -¥61,567M | -¥30,087M | -¥132,434M | -¥77,382M |
| Financing CF | -¥123,055M | -¥111,061M | -¥6,753M | -¥137,684M |
| Free CF | ¥64,857M | ¥44,594M | ¥96,052M | ¥114,808M |
| Efficiency | ||||
| ROE | 11.02% | 12.24% | 10.69% | 9.41% |
| ROA | 5.20% | 6.22% | 4.93% | 4.08% |
Latest IR Information
-
Fiscal Year Ending March 2027 First Quarter Financial Results Report [IFRS] (Consolidated)
For the first quarter of the consolidated fiscal year ending March 2027, consolidated net sales were 412.1 billion yen, up 113.2% YoY; operating profit was 60.1 billion yen; net income attributable to owners of the parent was 36.4 billion yen....
Read more -
Notice Regarding Revision of Full-Year Consolidated Earnings Forecast
Driven by strong performance in the HealthCare and other segments, we revise upward the full-year consolidated net sales to 1,732,000 million yen, operating income to 2,020 million yen, and net income attributable to owners of the parent to 1,235 million...
Read more -
Announcement of Basic Policy on Absorption-type Merger with Ajinomoto Fine-Techno Co., Ltd.
Ajinomoto Co., Inc. will absorb Ajinomoto Fine-Techno Co., Ltd. as a wholly owned subsidiary. The effective date is planned to be April 1, 2027. Procedures will be a simplified merger and a short-form merger; surviving company: Ajinomoto Co., Inc.; disappearing...
Read more -
Ajinomoto Co., Inc. Notice of Continuation of the Mid-term Performance-linked Compensation System
Ajinomoto announced on July 29, 2026, the continuation of its mid-term performance-linked compensation system, covering the period from April 1, 2026, to March 31, 2029. Details are provided regarding evaluation indicators and achievement rates.
Read more -
Announcement Regarding the Status of Share Buyback
Target shares: 1,176,600 ordinary shares, total amount 6,091,394,595 yen, buyback period from June 1, 2026 to June 30, 2026, method: market purchases. In prior resolutions, up to 30 million shares and up to 80 billion yen were planned for cancellation...
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥5,889
Rating Score: 1.86 (Based on 14 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Ajinomoto Co., Inc. engages in the seasonings and foods, frozen foods, and healthcare and other businesses in Japan and internationally. The company operates through three segments: Seasonings and Foods; Frozen Foods; and Healthcare, etc. The Seasonings and Foods segment offers sauces and seasoning products under the AJI-NO-MOTO, HON-DASHI, Cook Do, Ajinomoto KK Consommé, Pure Select Mayonnaise, Ros Dee, Masako, Aji-ngon, Sazón, Sajiku, and CRISPY FRY names. This segment also provides instant noodles under the Knorr Cup Soup and YumYum names; coffee beverages under the Birdy and Blendy brands; powdered drink under the Birdy 3in1 name; MAXIM brand products; A Little Luxury Coffee Shop brand products and various gifts, office drinks, cup vending machines, and tea dispensers, etc. The Frozen Foods segment offers Gyoza dumplings, rice dishes, noodles, sweets, shumai, processed chicken, and other products. The Healthcare, etc segment provides amino acids for applications in various industries, such as pharmaceuticals and foods; contract development and manufacturing services for pharmaceutical intermediates and active ingredients, and sterile preparations. This segment also offers Ajinomoto Build-up Film, an interlayer insulating material for semiconductor packages; functional materials under the Plainset names; AFTINNOVA, such as activated carbon, release paper, etc.; feed amino acids, sports nutrition under the brand Aminovital, personal care materials under the brand Amisoft, amino acid-based makeup oil under the brand Eldew, and powder under the brand Amihope, medical foods, and agricultural services, etc. Ajinomoto Co., Inc. was founded in 1909 and is headquartered in Tokyo, Japan.